https://de.marketscreener.com/kurs/aktie/ACLARIS-THERAPEUTICS-INC-26123625/news/Aclaris-Therapeutics-Inc-gibt-vorlaufige-Topline-Daten-der-12-wochigen-Phase-2A-Studie-mit-orale-43178149/?utm_source=telegram&utm_medium=social&utm_campaign=share